New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Het rapport

Geverifieerd nieuws over financiering, hoofdkantoren en leiderschap van 's werelds meest innovatieve bedrijven

29 rapporten en meer

Dagelijks bijgewerkt met de nieuwste marktinformatie

Cloverleaf Bio Raises $33M Seed Round for RNA Cancer Therapeutics

Cloverleaf Bio closed an oversubscribed $33 million seed round to advance engineered tRNA therapeutics for liver and colorectal cancers.

Boulevard Bio Launches With Approximately $65M From Deerfield for Precision Immunology

Boulevard Bio announced its emergence from stealth with approximately $65 million in aggregate financing from Deerfield and affiliates, provided in equity capital and convertible notes.

Infinimmune Raises $75M Series A for Human-Derived Antibody Drugs

Infinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance human-derived antibody programs in atopic dermatitis and inflammatory disease.

Dualitas Therapeutics

Dualitas Therapeutics Appoints Karim Dabbagh Chief Executive Officer

Dualitas Therapeutics appointed Karim Dabbagh, formerly President and CEO of Silver Creek Pharmaceuticals, as Chief Executive Officer, with former interim CEO Rich Murray remaining on the Board of Directors.

Diagonal Therapeutics